Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06055257 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Not Yet Recruiting to Recruitingv4 Show 5 more changesShow less
    • Primary completion date: Oct 2025 to Dec 2027
    • Start date changed from estimate of May 1, 2024 to Jan 16, 2025
    • Study sites: 0 to 1
    • Study completion date: Nov 2025 to Dec 2027
    • Eligibility criteria expanded, about 139 words
  2. Notable Start date: Dec 15, 2023 to May 1, 2024
    • Eligibility criteria expanded, about 200 words
    v3
  3. Notable Start date: Oct 2023 to Dec 15, 2023v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Radiation is commonly used to treat cancer in the head and neck, however, this can lead to a serious complication called osteoradionecrosis (ORN), where there is necrotic (dead) open bone inside or outside of the mouth. This complication is difficult to treat, involves large healthcare costs, and can have devastating effects on quality of life. Two common adjuncts used in treatment of ORN are hyperbaric oxygen therapy (HBOT), which may requires up to 60 treatments at a specialized clinic where patients are treated with high concentrations of oxygen using special chambers, and a less complex option called PENTOCLO which involves treating patients with several antibiotics followed by a combination of other oral medications taken for at least 1 year. This pilot study will be guide the design of a definitive trial to examine if the combination of HBOT and a modified PENTOCLO protocol together is better than the current standard treatment of HBOT alone. Outcomes will include pain, side effects and the need for surgery in patients with ORN. Specifically, the results of this small, pilot study will help to inform the design of a future larger study.
Trial Details
NCT Number NCT06055257
Lead Sponsor Sunnybrook Health Sciences Centre
Conditions
(from sponsor)
Osteoradionecrosis, Osteoradionecrosis of Jaw, Osteoradionecrosis of the Mandible
Related terms Head and Neck Neoplasms, Osteoradionecrosis
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov